Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mingfang Xu

Showing results (11-20 of 41) with videos related to

Pageof 5
Sort By:
American Journal of Physiology. Gastrointestinal and Liver Physiology|April 26, 2019
LINC01018 confers a novel tumor suppressor role in hepatocellular carcinoma through sponging microRNA-182-5pShuai Wang, Mingfang Xu, Zhengang Sun, et al.
Frontiers in Immunology|April 13, 2026
Clonal tracing of rare anal metastasis in esophageal squamous cell carcinoma: a case report with whole-exome sequencing and multimodal therapyYuzhu Jiang, Yu Pu, Zhou Huang, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|April 27, 2017
[Effect of Nm23-H1 Nuclear Localization on Proliferation of 
Human Lung Adenocarcinoma Cell Line A549]Ya Sheng, Yanli Xiong, Mingfang Xu, et al.
Sheng Wu Gong Cheng Xue Bao = Chinese Journal of Biotechnology|March 13, 2010
[Preparation and identification of recombinant PTD-maxadilan]Le Zeng, Rongjie Yu, Mingfang Xu, et al.
Biomolecules & Biomedicine|February 1, 2023
Establishment of predictive nomogram and web-based survival risk calculator for desmoplastic small round cell tumor: A propensity score-adjusted, population-based studySihao Chen, Yu Pu, Yuzhu Jiang, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|January 11, 2020
Plasminogen activator inhibitor-1 (PAI-1) 4G/5G promoter polymorphisms and risk of venous thromboembolism - a meta-analysis and systematic reviewQiang Zhang, YunRui Jin, XueMei Li, et al.
Scientific Reports|July 2, 2025
Anlotinib plus camrelizumab and chemotherapy as first-line treatment in patients with advanced esophageal squamous cell carcinomaMingfang Xu, Yu Pu, Yuzhu Jiang, et al.
Future Oncology (London, England)|January 22, 2025
Impact of APOBEC3s on the occurrence, development and prognosis of esophageal squamous cell carcinomaFan Yang, He Xiao, Xiaoyan Dai, et al.
Plos One|August 7, 2020
Clinical characteristics and risk of second primary lung cancer after cervical cancer: A population-based studyChengyuan Qian, Hong Liu, Yan Feng, et al.
Oncology Letters|June 25, 2014
Combined chemotherapy plus endostar with sequential stereotactic radiotherapy as salvage treatment for recurrent esophageal cancer with severe dyspnea: A case report and review of the literatureMingfang Xu, Huan Huang, Yanli Xiong, et al.
Pageof 5

Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
American Journal of Physiology. Gastrointestinal and Liver Physiology|April 26, 2019
LINC01018 confers a novel tumor suppressor role in hepatocellular carcinoma through sponging microRNA-182-5pShuai Wang, Mingfang Xu, Zhengang Sun, et al.
Frontiers in Immunology|April 13, 2026
Clonal tracing of rare anal metastasis in esophageal squamous cell carcinoma: a case report with whole-exome sequencing and multimodal therapyYuzhu Jiang, Yu Pu, Zhou Huang, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|April 27, 2017
[Effect of Nm23-H1 Nuclear Localization on Proliferation of 
Human Lung Adenocarcinoma Cell Line A549]Ya Sheng, Yanli Xiong, Mingfang Xu, et al.
Sheng Wu Gong Cheng Xue Bao = Chinese Journal of Biotechnology|March 13, 2010
[Preparation and identification of recombinant PTD-maxadilan]Le Zeng, Rongjie Yu, Mingfang Xu, et al.
Biomolecules & Biomedicine|February 1, 2023
Establishment of predictive nomogram and web-based survival risk calculator for desmoplastic small round cell tumor: A propensity score-adjusted, population-based studySihao Chen, Yu Pu, Yuzhu Jiang, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|January 11, 2020
Plasminogen activator inhibitor-1 (PAI-1) 4G/5G promoter polymorphisms and risk of venous thromboembolism - a meta-analysis and systematic reviewQiang Zhang, YunRui Jin, XueMei Li, et al.
Scientific Reports|July 2, 2025
Anlotinib plus camrelizumab and chemotherapy as first-line treatment in patients with advanced esophageal squamous cell carcinomaMingfang Xu, Yu Pu, Yuzhu Jiang, et al.
Future Oncology (London, England)|January 22, 2025
Impact of APOBEC3s on the occurrence, development and prognosis of esophageal squamous cell carcinomaFan Yang, He Xiao, Xiaoyan Dai, et al.
Plos One|August 7, 2020
Clinical characteristics and risk of second primary lung cancer after cervical cancer: A population-based studyChengyuan Qian, Hong Liu, Yan Feng, et al.
Oncology Letters|June 25, 2014
Combined chemotherapy plus endostar with sequential stereotactic radiotherapy as salvage treatment for recurrent esophageal cancer with severe dyspnea: A case report and review of the literatureMingfang Xu, Huan Huang, Yanli Xiong, et al.
Pageof 5